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doi:10.1016/j.kjms.2010.09.003Abstract The aims of this study were to compare the quality of life (QOL) between subjects
with and without heroin use and to examine the association of QOL with sociodemographic
characteristics, characteristics of heroin use, family support, and depression among heroin
users at entry to a methadone maintenance treatment program. A group of 123 heroin users
who visited an outpatient addiction treatment clinic in southern Taiwan for methadone main-
tenance treatment were recruited into this study. We also recruited 106 subjects who had
never used heroin as the control group. Their QOL status was assessed by the short form of
the Taiwan Version of the World Health Organization Questionnaire on Quality of Life (the
WHOQOL-BREF Taiwan version). The level of QOL between subjects with and without heroin
use was compared, and the correlates of QOL among heroin users were examined. Heroin users
had poorer QOL than nonusers in the physical, psychological, and social relationship domains
but not the environment domain of the WHOQOL-BREF after controlling for the influences of
other factors. In addition, heroin users with obvious depression had poorer QOL in all four
domains than those without obvious depression. Also, heroin users who perceived higher family
support had better QOL in the social relationship and environment domains. Heroin users had
poorer QOL than nonusers in multiple domains. Relief of depressive symptoms and enhance-
ment of family support should be important strategies to improve QOL in heroin users.
摘要 本研究的目的在於比較海洛因使用者和非海洛因使用者生活品質的差異，並探討海洛因使
用者在接受美沙酮維持治療前的生活品質和社會人口學資料、海洛因使用情形、家庭支持度和憂
鬱程度之間的關連性。本研究以台灣簡明版世界衛生組織生活品質問卷，比較123位海洛因使用of Psychiatry, Tainan Hospital, No. 125, Jhongshan Road, West Central District, Tainan City 700,
net.net (H.-C. Chang).
vier Taiwan LLC. All rights reserved.
178 C.-N. Yen et al.者和106位非海洛因使用者對照組個案之生活品質高低，同時調查海洛因使用者的生活品質之相
關因子為何。海洛因使用者在生理、心理、社會關係等生活品質分項目皆比對照組個案較差，但
在環境分項目上則無顯著差異。有多重因子與海洛因使用者的生活品質高低具相關性，包括合併
顯著憂鬱者的生活品質在四個分項上皆較差，感受到較高家庭支持度者在社會關係及環境分項上
有較佳之生活品質。由本研究結果可知：海洛因使用者的生活品質在許多分項上皆比非海洛因使
用者差，改善憂鬱症狀及增加家庭支持度可以有效改善其生活品質。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Quality of life (QOL) has attracted a great deal of interest in
health science since 1980 [1e4]. Attention to QOL in
patients with medical problems is an emphasis on a holistic
view of health care [5]. QOL is defined as individuals’
perceptions of their position in life in the context of the
culture and value systems in which they live and in relation
to their goals, expectations, standards, and concerns; it is
a broad ranging concept, incorporating in a complex way
the persons’ physical health, psychological state, level of
independence, social relations, personal beliefs, and rela-
tionship to salient features of the environment [6]. QOL has
four uses in medicine: (1) for planning clinical care of
individual patients; (2) as an outcome measure in clinical
trials and health services research; (3) for assessment of
the health needs of populations; and (4) for resource allo-
cation [7].
There are several reasons to examine the level of QOL in
heroin users. First, addiction to illicit drugs is a cluster of
physiological, behavioral, and cognitive phenomena [8],
which can damage individuals’ physical and mental health,
role performance, and social adaptation [9e13]. Basically,
QOL measures involve two primary dimensionsdphysical
and mental functioning. Examining the level of QOL
provides knowledge of heroin users’ subjective perspec-
tives of their impairment in a multidimensional view of
their lives. Second, heroin-using behavior is a chronic
relapsing problem that is difficult to cure [14]. Assessments
of the impact of heroin use on QOL are important for
decisions about how aggressively the problematic behavior
should be treated, assessing the health needs of patients,
and allocating resources [7]. Third, QOL has been
acknowledged as an important prognostic variable in the
evaluation of the effects and outcome of treatment for
heroin use, such as in methadone maintenance treatment
(MMT) [15e20]. Previous research found that heroin users
entering MMT had significantly worse physical and psycho-
logical health than the general population [18,21,22]. Their
substantial physical and psychological impairment was
greater than that of patients with chronic obstructive
pulmonary disease [23], patients about to undergo heart
surgery [24], and those with coronary artery disease [25]. In
addition, heroin use also led to poor QOL in the social
domain [18,21,22,26e28]. Varies factors, such as gender,
polysubstance use, educational level, HIV status, dual
diagnosis, and personality disorder, were associated with
poor QOL among heroin users [15,28e30]. On the other
hand, MMT has also been found to improve the QOL of
heroin users [18,19,31]. However, very few studies have
evaluated the correlates of QOL in heroin users at entry toMMT. Understanding these correlates may provide a basis to
develop intervention strategies to improve the QOL of
heroin users. Thus, the aims of this study were (1) to
examine whether the different domains of QOL are
affected by heroin use by comparing the QOL of subjects
with and without heroin use and (2) to examine the asso-
ciation of QOL with sociodemographic characteristics,
characteristics of heroin use, family support, and depres-
sion among heroin users entering MMT programs.MethodsParticipants
A group of 123 heroin users who visited an outpatient
addiction treatment clinic in southern Taiwan for MMTwere
recruited into this study. The data in this study were
collected before they started MMT. We also used subjects
recruited from a previous study [32] who had never used
heroin for the control group. We posted an advertisement
in the hospital and in newspapers to invite heroin nonusers
to participate in the study. A total of 157 persons respon-
ded to the advertisement. A psychiatrist assessed all
responders systematically to determine whether they had
any substance use disorders or psychotic disorders using the
structured Mini-International Neuropsychiatric Interview
[33]. Those who had any substance use disorders or
psychotic disorders, drank alcohol more than once per
month, or had low mentality were excluded. A total of 106
subjects conformed to the criteria and were recruited as
the control group.
Survey instruments
World Health Organization Questionnaire on Quality of
Life: Short FormdTaiwan version
The World Health Organization Questionnaire on Quality of
Life: Short FormdTaiwan version (WHOQOL-BREF) was
developed by the WHO to evaluate health-related QOL and
make cross-cultural comparisons [6]. It has been adapted
for use in Taiwan [34]. The WHOQOL-BREF Taiwan version
contains 28 five-point items that assess general (two items)
and four specific domains of QOL, including 7 items in
physical health, 6 in psychological, 4 in social relation-
ships, and 9 in environmental domains, with well-estab-
lished validity and reliability [34]. The transformed scores
of the four QOL domains range from 0 to 100. Higher scores
on the WHOQOL-BREF Taiwan version indicate a higher
perceived QOL.
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The 20-item Center for Epidemiological Studies Depression
Scale (CES-D) is a self-administered four-point scale
assessing frequency of depressive symptoms in the
preceding week, with scores ranging from 0 (never or
rarely) to 3 (always) [35]. The Taiwanese version of the
CES-D has been used for studying depression in Taiwan for
many years [36] and possible total scores range from 0 to
60, with higher scores indicating more severe depression. A
score of 17 or more is classified as obvious depression [35].
Family APGAR index
The Taiwanese version of the family APGAR [37] is based on
the original version developed by Smilkstein [38]. The five-
point response scales reflect frequency ranging from never
to always. High scores indicate good family support.Procedure and statistical analysis
The protocol was approved by the Institutional Review
Board of Tainan Hospital Department of Health, Executive
Yuan. Informed consent was obtained from all subjects
before commencement of the study. Two research assis-
tants evaluated the characteristics of heroin use and
explained how to complete the self-administered ques-
tionnaires. If the participants had difficulty understanding
the content of the questionnaires, researchers read the
questions to them to maximize comprehension and reli-
ability. Sociodemographic characteristics and family
support on the APGAR Index were also collected from the
subjects in the control group. Among the heroin users and
nonusers, the influences of the characteristics of heroin
users on the four QOL domains on the WHOQOL-BREF
Taiwan version were examined using multiple linearTable 1 Sociodemographic and survey data
Heroi
Mean (SD)
Socio-demographic characteristics
Age, yr 37.8 (8.0)
Education, yr 9.6 (2.3)
Gender, female
Married
Family support on the APGAR 12.2 (2.5)
CES-D 17
Characteristics of heroin use
Use illicit drugs except for heroin
Spend more than NT$ 30,000/mo on heroin use
Duration from the first heroin use, yr 11.5 (7.4)
Criminal records of heroin use
Quality of life on WHOQOL-BREF Taiwan version
Physical 53.0 (15.1)
Psychological 46.9 (16.8)
Social relationship 51.3 (15.8)
Environment 49.5 (13.2)
APGARZ family APGAR index; CES-DZ The Center for Epidemio
SDZ standard deviation; WHOQOL-BREF Taiwan versionZWorld Hea
Taiwan version.regression analysis by controlling for sex, age, education,
marriage, and family support. Among the heroin users, the
associations of the four QOL domains with subjects’ sex,
age, education, marriage, family support, depression, and
characteristics of heroin use were examined using multiple
linear regression analysis. A two-tailed p-value less than
0.05 was considered statistically significant.
Results
Survey data on heroin users and nonusers and characteristics
of heroin use in heroin users are shown in Table 1. The
influences of heroin use on the four QOL domains were
examined using multiple linear regression analysis by
controlling for sociodemographic characteristics and family
support and the results are shown inTable 2.Heroin users had
poorer QOL than nonusers in the physical, psychological, and
social relationship domains after controlling for the influ-
ences of other factors. However, no difference between
users and nonusers was found in the environment domain.
In heroin users, the associations betweenQOL and several
variables were examined using multiple linear regression
analysis (Table 3). The results indicated that by controlling
for the influence of other factors, heroin users with
obvious depression had poorer QOL in all four domains of the
WHOQOL-BREF than those without obvious depression.
Meanwhile, heroin users who perceived high family support
had better QOL in the social relationship and environment
domains.
Discussion
In line with the results of a previous study [39], this study
found that heroin users had poorer QOL than nonusers inn users (nZ 123) Heroin nonusers (nZ 106)
Range n (%) Mean (SD) Range n (%)
24e60 33.8 (8.1) 18e50
3e19 12.0 (1.1) 9e16
20 (16.3) 55 (51.9)
29 (23.6) 38 (35.8)
5e20 14.3 (3.2) 5e20
88 (71.5)
67 (54.5)
57 (46.3)
0.5e35
32 (26.0)
13e88 70.5 (11.9) 38e94
0e88 54.1 (12.3) 25e81
6e100 61.7 (13.4) 25e94
19e88 51.6 (16.1) 19e75
logical Studies Depression Scale; NT$Z new Taiwan dollar;
lth Organization Questionnaire on Quality of Life: Short Formd
Table 2 The effect of heroin use on quality of life by controlling the effects of family support, age, sex, education, and marriage in multiple linear regression analyses
Physical parameter Psychological parameter Social relationship parameter Environment parameter
Estimate 95% CI p Estimate 95% CI p Estimate 95% CI p Estimate 95% CI p
Heroin use (1) vs.
heroin nonuse (0)
16.470 20.858, 12.082 <0.001 6.334 10.996, 1.671 0.008 8.219 12.701, 3.738 <0.001 0.079 3.784, 3.626 0.966
Total APGAR scores 0.821 0.272, 1.371 0.004 1.327 0.743, 1.910 <0.001 1.369 0.808, 1.930 <0.001 1.319 0.855, 1.783 <0.001
Age, yr 0.031 0.198, 0.260 0.788 0.010 0.233, 0.254 0.934 0.050 0.284, 0.184 0.675 0.016 0.178, 0.209 0.875
Females (1) vs. males (0) 2.322 6.553, 1.909 0.281 0.842 5.338, 3.654 0.712 5.737 1.416, 10.058 0.009 0.743 2.829, 4.316 0.682
Education, yr 0.810 0.180, 1.801 0.108 0.297 0.755, 1.349 0.579 0.300 1.311, 0.712 0.560 0.662 0.174, 1.498 0.120
Married (1) vs. unmarried (0) 0.716 4.797, 3.365 0.730 2.234 2.102, 6.570 0.311 2.852 1.316, 7.020 0.179 0.521 3.967, 2.925 0.766
Regular R2 0.334 0.150 0.247 0.163
APGARZ family APGAR index; CIZ confidence interval.
Table 3 Variables associated with quality of life among the subjects with heroin use in multiple linear regression analyses
Physical parameter Psychological parameter Social relationship parameter Environment parameter
Estimate 95% CI p Estimate 95% CI p Estimate 95% CI p Estimate 95% CI p
Females (1) vs. males (0) 2.847 10.243, 4.550 0.447 3.418 4.712, 11.548 0.407 5.512 2.287, 13.311 0.164 2.039 8.357, 4.280 0.524
Age, yr 0.148 0.606, 0.310 0.523 0.168 0.335, 0.672 0.510 0.123 0.360, 0.607 0.614 0.153 0.239, 0.544 0.441
Education duration, yr 0.402 0.764, 1.567 0.496 0.160 1.441, 1.121 0.805 0.386 1.615, 0.842 0.535 0.675 0.320, 1.671 0.182
Married (1) vs. unmarried (0) 2.676 8.809, 3.457 0.389 0.763 5.978, 7.504 0.823 1.525 4.941, 7.992 0.641 0.669 5.908, 4.569 0.801
Illicit drugs except for heroin:
use (1) vs. nonuse (0)
2.555 8.219, 3.109 0.373 0.253 6.479, 5.973 0.936 4.061 1.911, 10.034 0.181 3.843 0.996, 8.682 0.118
Spend more than NT$ 30,000/mo
on heroin use
0.304 5.102, 5.710 0.912 1.188 4.754, 7.130 0.693 1.008 6.709, 4.692 0.727 1.105 5.724, 3.513 0.636
Duration from the first
heroin use, yr
0.122 0.615, 0.371 0.624 0.343 0.885, 0.198 0.212 0.123 0.643, 0.396 0.640 0.355 0.776, 0.066 0.097
Criminal records of heroin use:
yes (1) vs. no (0)
2.836 9.441, 3.769 0.397 1.571 8.831, 5.689 0.669 0.184 7.149, 6.780 0.958 0.463 5.180, 6.105 0.871
Total APGAR scores 0.217 0.556, 0.990 0.579 0.849 0.001, 1.698 0.050 1.155 0.340, 1.971 0.006 1.135 0.475, 1.796 0.001
CES-D 17 (1) vs. CES-D< 17 (0) 12.510 18.315, 6.704 <0.001 15.130 21.511, 8.749 <0.001 11.604 17.725, 5.482 <0.001 8.305 13.264, 3.346 0.001
Regular R2 0.215 0.230 0.202 0.247
APGARZ family APGAR index; CES-DZ The Center for Epidemiological Studies Depression Scale; CI: confidence interval.
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Quality of life in heroin abusers 181the physical, psychological, and social relationship domains
after controlling for the influences of other factors.
Previous studies have found that heroin use can damage
individuals’ physical and mental health, role performance,
and social adaptation [9e13]. Heroin use can harm
psychological health directly or through the effects on
interpersonal and role functioning [10,40,41]. The results of
this study further demonstrate that heroin users can iden-
tify adverse physical and psychological conditions and
social relationships they have encountered. Research has
found that when enhancing subjects’ motivation to change
addictive behaviors, one of the major principles is to help
them perceive the discrepancy between present behavior
and important personal goals or values [42]. Thus, the
results of this study indicated that clinicians should
confer with heroin users about their perspectives on their
satisfaction with the physical, psychological, and social
relationship domains of QOL and motivate change of
heroin-using behaviors.
Research has found that heroin users have high rates of
unemployment, criminal records, and low educational
levels [30]. They also have high risks for illness and death
[30]. One might have predicted that heroin users have
a poorer environment domain of QOL than heroin nonusers.
However, this study found no difference in the environment
domain between users and nonusers. One possible expla-
nation is that the subjects in this study were entering MMT
programs of their own free will and may have had better
economic status and less criminal activity than heroin users
with severe economic and legal problems. The results of
this study indicated that QOL is not homogenous and single
dimensional in heroin users; however, the reasons for the
heterogeneous association between different domains of
QOL and heroin use need further study.
The second important finding of this study is that heroin
users with obvious depression had poorer QOL on all four
domains of the WHOQOL-BREF than those without obvious
depression. Previous research demonstrated that major
depression is the most prevalent psychiatric comorbidity in
heroin users, and 15.8e56% of heroin users have a diagnosis
of major depression [43e46]. Psychiatric comorbidity can
lower the QOL in the physical, psychological, and
social domains in heroin addicts [22,24,47,48]. Meanwhile,
individuals with psychiatric comorbidity often have more
difficulty gaining access to treatment and in service
utilization and have less successful outcomes than those
without this comorbidity [49e52] Patients with dual diag-
noses have poor psychosocial functioning and less adequate
social support networks [49,53,54] than those without
psychiatric comorbidity. They also receive less outpatient
treatment and have poorer physical health [47]. This
finding reminds clinicians that it is necessary to take
comorbid depression into consideration when approaching
heroin users. Treating depression should be an important
step in helping heroin users change heroin-using behaviors.
Another important finding of this study is that heroin
users who perceived higher family support had better
QOL on social relationship and environment domains. Self-
perceived high family support usually means that the
subjects have good family function and relationships, which
implies that heroin users would be offered financial support,
a physically secure environment, health and social care,utilization of social resources, and a home environment by
their families. That might be the explanation for the asso-
ciation between perceived family support and subjective
QOL on social relationship and environment domains.
Accordingly, family support is an important factor influ-
encing the QOL of heroin users. Psychosocial intervention to
increase family support and maintain good family relation-
ships is needed when recruiting heroin users into MMT.
Several limitations of our study need to be considered.
First, the results of QOL were based on subjects’ self-
reports, not objective measures. The severity may have
been underestimated because of the sensitive nature of
admitting to criminal records and deviant behavior. Second,
a cross-sectional retrospective survey limits the ability to
establish the causality of the results. Further longitudinal
advanced study is needed to acquire more information
for analysis. Third, the subjects in this study entered
MMT for heroin abstinence voluntarily. Their characteristics
of heroin use, psychiatric comorbidity, and QOL may be
different from heroin users who did not receive MMT.
Finally, further follow-up studies are needed to examine
the effects of MMT on the changes of QOL in heroin users.
In conclusion, the results of this study indicate that
heroin users have poorer QOL than nonusers in the physical,
psychological, and social relationship domains but not in
the environmental domain. Comorbid depression and
perceived poor family support were associated with some
domains of compromised QOL in heroin users. Based on the
results of this study, clinicians should monitor the impact of
heroin use on QOL and the treatment plan should be
multidisciplinary, including medical, social, and psychiatric
components. Relief of depressive symptoms and enhance-
ment of family support are important strategies to improve
the QOL in heroin users.Acknowledgment
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